Ascendis Health Statistics

Total Valuation

Ascendis Health has a market cap or net worth of ZAR 563.18 million. The enterprise value is 566.67 million.

Market Cap	563.18M
Enterprise Value	566.67M

Important Dates

The next estimated earnings date is Friday, December 27, 2024.

Earnings Date	Dec 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Ascendis Health has 625.75 million shares outstanding. The number of shares has increased by 3.27% in one year.

Current Share Class	n/a
Shares Outstanding	625.75M
Shares Change (YoY)	+3.27%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.47%
Owned by Institutions (%)	0.05%
Float	48.94M

Valuation Ratios

The trailing PE ratio is 13.55.

PE Ratio	13.55
Forward PE	n/a
PS Ratio	0.38
PB Ratio	0.91
P/TBV Ratio	0.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.77, with an EV/FCF ratio of -12.54.

EV / Earnings	9.89
EV / Sales	0.38
EV / EBITDA	8.77
EV / EBIT	74.96
EV / FCF	-12.54

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.09.

Current Ratio	1.88
Quick Ratio	0.88
Debt / Equity	0.09
Debt / EBITDA	0.84
Debt / FCF	-1.20
Interest Coverage	1.33

Financial Efficiency

Return on equity (ROE) is 7.04% and return on invested capital (ROIC) is 0.73%.

Return on Equity (ROE)	7.04%
Return on Assets (ROA)	0.46%
Return on Capital (ROIC)	0.73%
Revenue Per Employee	105.15M
Profits Per Employee	4.09M
Employee Count	14
Asset Turnover	1.45
Inventory Turnover	2.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.27% in the last 52 weeks. The beta is 0.64, so Ascendis Health's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	-1.27%
50-Day Moving Average	73.46
200-Day Moving Average	75.56
Relative Strength Index (RSI)	75.71
Average Volume (20 Days)	8,489,649

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ascendis Health had revenue of ZAR 1.47 billion and earned 57.29 million in profits. Earnings per share was 0.09.

Revenue	1.47B
Gross Profit	585.18M
Operating Income	7.56M
Pretax Income	40.37M
Net Income	57.29M
EBITDA	51.13M
EBIT	7.56M
Earnings Per Share (EPS)	0.09

Full Income Statement

Balance Sheet

The company has 50.63 million in cash and 54.12 million in debt, giving a net cash position of -3.49 million or -0.01 per share.

Cash & Cash Equivalents	50.63M
Total Debt	54.12M
Net Cash	-3.49M
Net Cash Per Share	-0.01
Equity (Book Value)	618.27M
Book Value Per Share	0.99
Working Capital	359.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.11 million and capital expenditures -37.09 million, giving a free cash flow of -45.20 million.

Operating Cash Flow	-8.11M
Capital Expenditures	-37.09M
Free Cash Flow	-45.20M
FCF Per Share	-0.07

Full Cash Flow Statement

Margins

Gross margin is 39.75%, with operating and profit margins of 0.51% and 3.89%.

Gross Margin	39.75%
Operating Margin	0.51%
Pretax Margin	2.74%
Profit Margin	3.89%
EBITDA Margin	3.47%
EBIT Margin	0.51%
FCF Margin	n/a

Dividends & Yields

Ascendis Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.27%
Shareholder Yield	-3.27%
Earnings Yield	10.17%
FCF Yield	-8.03%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ascendis Health has an Altman Z-Score of -4.84. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.84
Piotroski F-Score	n/a